Avient
Avient's revenue rose 0.6% to $3.3 billion in fiscal 2025. Its operating margin was 6.2%, down from 10.2% a year earlier. Free cash flow was $195 million, up 44.5%. It paid out $99 million in dividends and buybacks, 51% of free cash flow. The diluted share count fell 0.2%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2016 to 2025, earnings per share fell 8.3% a year and net income 7.5% a year, as new shares raised the share count by 9% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Avient yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Avient's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Avient's fiscal 2025 free cash flow of $195M, net cash of −$1.4B at December 31, 2025 and 92 million diluted shares, from its filings. The scenarios are fitted to Avient: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, -1.4% a year, kept between 0% and 20%; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 12%: 11% for a cyclical or higher-risk business (Specialty Chemicals), plus 1 point as a smaller company, worth $3.8B; the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $41.28
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Avient's earnings per share of $1.85 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 22.3×, the middle of Avient's own P/E today, its peers' median and its sector's median (Avient's own P/E today) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 13%, 12% and 11%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $41.28
- Value at this multiple, against the last close
- —
- Avient's P/E at the last close
- 22.3×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| Solstice Advanced MaterialsSOLS | $60.38 | $1.49 | 40.5× |
| Element SolutionsESI | $33.54 | $0.85 | 39.5× |
| AvientAVNT | $41.28 | $1.85 | 22.3× |
| NewMarketNEU | $878.03 | $46.49 | 18.9× |
| H.B. FullerFUL | $49.13 | $3.59 | 13.7× |
Balance sheet
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 601 | 641 | 546 | 544 | 510 |
| Debt incl. finance leases | 1,859 | 2,179 | 2,080 | 2,067 | 1,923 |
| Net debt (negative means net cash) | 1,258 | 1,538 | 1,534 | 1,522 | 1,413 |
| Net debt to EBITDA | 3.0x | 3.8x | 4.0x | 3.0x | 3.6x |
| Debt to equity | 1.1x | 0.9x | 0.9x | 0.9x | 0.8x |
| Interest coverage | — | — | — | — | — |
| Current ratio | 1.9x | 1.8x | 1.8x | 1.9x | 1.7x |
| Quick ratio | 1.6x | 1.4x | 1.4x | 1.4x | 1.2x |
Insider trades
No officer, director or 10% owner of Avient reported buying or selling its shares on the open market between October 27, 2025 and October 26, 2026.
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Pass |
| Current ratio rose | Pass | Pass | Fail |
| Share count didn't rise | Pass | Fail | Pass |
| Gross margin rose | Pass | Pass | Fail |
| Revenue rose relative to assets | Fail | Pass | Pass |
| F-score | 7 of 9 | 7 of 9 | 6 of 9 |
| Accruals ratio | −2.1% | −1.5% | −3.7% |
Compare
Put Avient side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Avient | FY25 | 0.6% | 6.2% | 6.0% | 4.0% | 3.6x | 6 | |
| H.B. Fuller | FY25 | −2.7% | — | 3.5% | 6.3% | 3.6x | 7 | Compare |
| Solstice Advanced Materials | FY25 | 3.1% | — | 3.1% | 12.2% | 2.3x | — | Compare |
| NewMarket | FY25 | −2.2% | 19.9% | 18.0% | 16.3% | 1.2x | 5 | Compare |
| Element Solutions | FY25 | 3.8% | 13.4% | 8.9% | 6.5% | 2.0x | 7 | Compare |
10 years of figures
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 2,939 | 2,590 | 2,881 | 2,863 | 2,215 | 3,316 | 3,397 | 3,143 | 3,240 | 3,260 |
| Revenue growth | 0.3% | −11.8% | 11.2% | −0.6% | −22.6% | 49.7% | 2.5% | −7.5% | 3.1% | 0.6% |
| Gross profit | 676 | 596 | 625 | 657 | 660 | 944 | 883 | 892 | 1,057 | 1,016 |
| Research and development | 50 | 45 | 50 | 51 | 60 | 83 | 85 | 90 | 99 | 97 |
| Operating income | 268 | 173 | 179 | 157 | 112 | 280 | 243 | 197 | 329 | 204 |
| Net income | 165 | −58 | 160 | 589 | 132 | 231 | 703 | 76 | 170 | 82 |
| Diluted EPS (US$) | 1.95 | −0.70 | 1.99 | 7.58 | 1.45 | 2.51 | 7.63 | 0.83 | 1.84 | 0.89 |
| Diluted shares (millions) | 85 | 82 | 80 | 78 | 91 | 92 | 92 | 92 | 92 | 92 |
| Cash flow | ||||||||||
| Cash from operations | 228 | 202 | 254 | 301 | 222 | 234 | 398 | 202 | 257 | 302 |
| Capital expenditure | 84 | 80 | 76 | 82 | 64 | 101 | 106 | 119 | 122 | 107 |
| Free cash flow | 143 | 123 | 178 | 219 | 158 | 133 | 293 | 82 | 135 | 195 |
| Dividends paid | 40 | 44 | 56 | 60 | 71 | 78 | 87 | 90 | 94 | 99 |
| Share buybacks | 86 | 71 | 123 | 27 | 22 | 4 | 36 | 0 | 0 | 0 |
| Acquisitions | 164 | 164 | 99 | 120 | 1,380 | 48 | 1,426 | 0 | 0 | 0 |
| Stock-based compensation | 8 | 10 | 11 | 12 | 11 | 11 | 13 | 13 | 15 | 9 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 227 | 244 | 171 | 865 | 650 | 601 | 641 | 546 | 544 | 510 |
| Debt incl. finance leases | 1,258 | 1,309 | 1,356 | 1,229 | 1,873 | 1,859 | 2,179 | 2,080 | 2,067 | 1,923 |
| Total assets | 2,736 | 2,705 | 2,723 | 3,273 | 4,870 | 4,997 | 6,085 | 5,968 | 5,811 | 6,026 |
| Total liabilities | 2,010 | 2,106 | 2,183 | 2,221 | 3,159 | 3,207 | 3,732 | 3,630 | 3,482 | 3,639 |
| Shareholders' equity | 725 | 598 | 540 | 1,052 | 1,697 | 1,775 | 2,334 | 2,319 | 2,314 | 2,374 |
| Margins and ratios | ||||||||||
| Gross margin | 23.0% | 23.0% | 21.7% | 23.0% | 29.8% | 28.5% | 26.0% | 28.4% | 32.6% | 31.1% |
| Operating margin | 9.1% | 6.7% | 6.2% | 5.5% | 5.0% | 8.4% | 7.2% | 6.3% | 10.2% | 6.2% |
| Net margin | 5.6% | −2.2% | 5.5% | 20.6% | 5.9% | 7.0% | 20.7% | 2.4% | 5.2% | 2.5% |
| Free cash flow margin | 4.9% | 4.7% | 6.2% | 7.7% | 7.1% | 4.0% | 8.6% | 2.6% | 4.2% | 6.0% |
| Return on capital | 11.8% | 10.1% | 9.1% | 6.9% | 5.1% | 7.0% | 7.0% | 4.4% | 6.5% | 4.0% |
| Return on equity | 23.1% | −8.7% | 28.1% | 74.0% | 9.6% | 13.3% | 34.2% | 3.2% | 7.3% | 3.5% |
| Return on assets | 6.2% | −2.1% | 5.9% | 19.6% | 3.2% | 4.7% | 12.7% | 1.3% | 2.9% | 1.4% |
| Net debt to EBITDA | 2.8x | 3.9x | 4.4x | 1.5x | 5.5x | 3.0x | 3.8x | 4.0x | 3.0x | 3.6x |